Burn Out & Quality of Life at French General Practioners

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The suffering of caregivers is constantly increasing. General medicine, because of its primary role in primary care, is particularly exposed to the risk of burn-out and must protect itself. The aim of this study was to find an inverse relationship between health-related quality of life and being severely burned by French general practitioners.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04086303` - Anthropometric and Physical Fitness Differences Among Turkish Adolescents and Adults Handball Players	N/A

NCT number	NCT04136899
Study type	Observational
Source	Centre Hospitalier St Esprit
Contact
Status	Completed
Phase
Start date	August 20, 2019
Completion date	August 20, 2019

Burn Out and Quality of Life at French General Practioners

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms